Member Info for cbeadle

This has to be a real bargain at this level. Great chance it could be bought out possibly by EMH which essentially owns the same deposit across the Czech border

A strong bitcoin price should mitigate today’s reaction to the placement news

Just got the feeling FAB is going to need patience. I think it’s fundamentally wrongly valued and 18-20p would probably reflect a fair valuation for where we are. For the foreseeable, we are staying around where we are unless some news comes

I completely agree, if FAB can finally deliver a favourable contract, perhaps JV it could run a long way

Why are they flying after a rubbish update, it doesn’t seem to make any sense?

Answer to my question in this RNS?!

Why would Argo be less, is it less highly geared than these other companies?

I totally agree , although Fusion has flatlined for a number of years, they have a healthy number of blue chip clients. Adrian Kinkaid is a recent new CEO , and these small life science companies can rerate 10-20x on the right news, FAB could do and still be well below £100m market cap. The drop has been well overdone, but I think they probably could have raised funds at 15p rather than 5p

ARB in the short term is a pure geared play on Bitcoin. If Bitcoin continues its recent gains we’re flying, but if not we’re going back down

It’s an interesting one. For years in the 1970-1980s in (West) Germany the central bank set interest rates, while in the UK it was the cabinet who decided. Germany kept a far better hold of inflation, and Sterling declined. I can remember 8DM to £ in 1971, yet this was about 4DM to £ in 1981! Germany had a much better performing economy. In the Brown-Blair period they gave the responsibility to the BOE, thinking that central banks were superior to politicians with these decisions. It is debatable, and probably we should have raised the rate shortly after the 2008 crash around 2.5%-3%. However, the BOE has become an easy target of criticism for politicians and others. Perhaps it’s time again to start trusting the Cabinet more than the BOE on interest rate decisions!

Interesting well known and established client list including Amgen, Bayer, Moderna and Pfizer amongst others. At the moment Fusion Antibodies priced like a speculative fly by night start up, which it’s absolutely not. If they could list in New York they would be worth much more

I think it will settle somewhere in this range after the adjustments with the placement etc. News such as collaborations could take it much higher, but we have lacked that. It feels we are overdue something

These micro cap companies can move very quickly with the right news, so just have to be on board, although usually patience needed

The deal is signed RNS 20-04-2023, they just need to announce further updates

Thanks roger65 it could be delayed

Some more big buy’s just showing

The latter two are certainly buys , one delayed from early in the morning. This was a strange sort of day, slow to get off the mark. However it looks like FAB could deliver at some point

There’s not much volume, I think we need to wait, but it is a further chance for those wanting to build their holding

I think we’re moving up again soon, the 5369 3rd buy of the day was mine

I wonder if it would be bought out? I was thinking more there would be collaboration agreements, fusion look a bit of a niche company. Certainly with their current market cap it wouldn’t take that much to see the share price surge on good news. The website has changed and the new CEO has seemingly more focus